Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
D3L-001 by D3 Bio for Solid Tumor: Likelihood of Approval
D3L-001 is under clinical development by D3 Bio and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
D3L-001 by D3 Bio for Gastric Cancer: Likelihood of Approval
D3L-001 is under clinical development by D3 Bio and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
D3L-001 by D3 Bio for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
D3L-001 is under clinical development by D3 Bio and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas. According to...
D3L-001 by D3 Bio for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
D3L-001 is under clinical development by D3 Bio and currently in Phase I for Human Epidermal Growth Factor Receptor 2...